← All trials
NCT05359055
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 13, 2021
- Primary completion
- Jan 21, 2022
- Completion date
- Jan 21, 2022
- First posted
- May 3, 2022
- Last posted
- Jul 29, 2022
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Pharmaceuticals Holding Co., LtdLead sponsor
- Sichuan UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.